Autophagy protects tumors from T cell–mediated cytotoxicity via inhibition of TNFα-induced apoptosis

Autophagy reduces tumor cell sensitivity to T cell killing; thus, inhibiting autophagy may improve T cell–engaging therapies. Autophagy protects tumors from T cells Tumors evade antitumor T cells by various mechanisms. Young et al. used a CRISPR screen to identify that TNFα and autophagy play a role in T cell–mediated killing of tumor cells. Pharmacologic or genetic (CRISPR knockout of Rb1cc1) inhibition of autophagy in tumor cells increased TNFα-mediated T cell killing of tumor cells. Rb1cc1 knockout in tumor cells improved the efficacy of immune checkpoint blockade in a mouse tumor model. However, CRISPR knockout of the TNFα receptor in tumor cells partially abrogated the improved efficacy of immune checkpoint blockade in the absence of Rb1cc1. Thus, autophagy inhibition may improve T cell–mediated immunotherapies in patients with cancer. Although T cell checkpoint inhibitors have transformed the treatment of cancer, the molecular determinants of tumor cell sensitivity to T cell–mediated killing need further elucidation. Here, we describe a mouse genome–scale CRISPR knockout screen that identifies tumor cell TNFα signaling as an important component of T cell–induced apoptosis, with NF-κB signaling and autophagy as major protective mechanisms. Knockout of individual autophagy genes sensitized tumor cells to killing by T cells that were activated via specific TCR or by a CD3 bispecific antibody. Conversely, inhibition of mTOR signaling, which results in increased autophagic activity, protected tumor cells from T cell killing. Autophagy functions at a relatively early step in the TNFα signaling pathway, limiting FADD-dependent caspase-8 activation. Genetic inactivation of tumor cell autophagy enhanced the efficacy of immune checkpoint blockade in mouse tumor models. Thus, targeting the protective autophagy pathway might sensitize tumors to T cell–engaging immunotherapies in the clinic.

[1]  Gary D Bader,et al.  Functional genomic landscape of cancer-intrinsic evasion of killing by T cells , 2020, Nature.

[2]  G. Berchem,et al.  Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy , 2020, Science Advances.

[3]  J. Debnath,et al.  Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I , 2020, Nature.

[4]  Yong Gu Lee,et al.  Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction. , 2020, Cancer discovery.

[5]  T. Aittokallio,et al.  Integrated drug profiling and CRISPR screening identify essential pathways for CAR T cell cytotoxicity. , 2019, Blood.

[6]  A. Thorburn,et al.  Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations , 2019, The Journal of cell biology.

[7]  J. Debnath,et al.  Targeting Autophagy in Cancer: Recent Advances and Future Directions. , 2019, Cancer discovery.

[8]  J. Schatz,et al.  T Cell–Activating Bispecific Antibodies in Cancer Therapy , 2019, The Journal of Immunology.

[9]  T. Schumacher,et al.  Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold , 2019, Cell.

[10]  E. Dolgin Anticancer autophagy inhibitors attract ‘resurgent’ interest , 2019, Nature Reviews Drug Discovery.

[11]  S. Akira,et al.  Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity. , 2019, Cell reports.

[12]  Qiuhe Lu,et al.  Atg14 protects the intestinal epithelium from TNF-triggered villus atrophy , 2019, Autophagy.

[13]  E. Petricoin,et al.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer , 2019, Nature Medicine.

[14]  J. Yap,et al.  Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers , 2019, Nature Medicine.

[15]  J. Allison,et al.  Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. , 2018, Cancer discovery.

[16]  K. Brown,et al.  Tumor immune evasion arises through loss of TNF sensitivity , 2018, Science Immunology.

[17]  D. Klionsky,et al.  Cargo recognition and degradation by selective autophagy , 2018, Nature Cell Biology.

[18]  Henry W. Long,et al.  A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing , 2018, Science.

[19]  K. Maloy,et al.  Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice. , 2018, Cell host & microbe.

[20]  Feng Zhang,et al.  Identification of essential genes for cancer immunotherapy , 2017, Nature.

[21]  John G Doench,et al.  In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target , 2017, Nature.

[22]  Ann E. Sizemore,et al.  Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, Nature Genetics.

[23]  H. Waldmann,et al.  Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34. , 2017, Angewandte Chemie.

[24]  H. Walczak,et al.  Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy , 2017, Nature Reviews Cancer.

[25]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[26]  Neville E. Sanjana,et al.  Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2017, Nature Protocols.

[27]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[28]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[29]  J. Debnath,et al.  Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. , 2016, The Journal of clinical investigation.

[30]  E. White,et al.  Recent insights into the function of autophagy in cancer , 2016, Genes & development.

[31]  M. Bertrand,et al.  More to Life than NF-κB in TNFR1 Signaling. , 2016, Trends in immunology.

[32]  T. Graeber,et al.  Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. , 2016, The New England journal of medicine.

[33]  J. McQuade,et al.  Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. , 2016, Cancer discovery.

[34]  Andrew D. Tustian,et al.  A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys , 2015, Scientific Reports.

[35]  N. Mizushima,et al.  Atg13 Is Essential for Autophagy and Cardiac Development in Mice , 2015, Molecular and Cellular Biology.

[36]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[37]  Julián Pardo,et al.  How Do Cytotoxic Lymphocytes Kill Cancer Cells? , 2015, Clinical Cancer Research.

[38]  K. Guan,et al.  mTOR: a pharmacologic target for autophagy regulation. , 2015, The Journal of clinical investigation.

[39]  Jun S. Liu,et al.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.

[40]  M. Mathieu,et al.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. , 2014, Nature chemical biology.

[41]  L. Macdonald,et al.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice , 2014, Proceedings of the National Academy of Sciences.

[42]  Eric H. Baehrecke,et al.  Self-consumption: the interplay of autophagy and apoptosis , 2014, Nature Reviews Molecular Cell Biology.

[43]  J. Zimmer,et al.  Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia , 2013, Proceedings of the National Academy of Sciences.

[44]  M. Czaja,et al.  Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation , 2013, Cell Death and Differentiation.

[45]  T. Tenev,et al.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. , 2011, Molecular cell.

[46]  W. Hou,et al.  Autophagic degradation of active caspase-8 , 2010, Autophagy.

[47]  Daniel J Klionsky,et al.  Mammalian autophagy: core molecular machinery and signaling regulation. , 2010, Current opinion in cell biology.

[48]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[49]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[50]  J. Guan,et al.  Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways , 2006, The Journal of cell biology.

[51]  S. Quezada,et al.  CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. , 2006, The Journal of clinical investigation.

[52]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[53]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[54]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[55]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[56]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[57]  P. Meier,et al.  Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer. , 2018, Trends in molecular medicine.

[58]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.